Acta Chir Orthop Traumatol Cech. 2019; 86(4):241-248 | DOI: 10.55095/achot2019/041
Economic Analysis of the Costs of Hospital Stay of Patients with Infection as a Complication of Total Replacements - Part 2: Total Hip ArthroplastyOriginal papers
- 1 Ortopedické oddělení, Nemocnice České Budějovice, a.s.
- 2 Zdravotně sociální fakulta, Jihočeská univerzita v Českých Budějovicích
- 3 Ekonomické oddělení, Nemocnice České Budějovice, a.s.
- 4 Ortopedická klinika Lékařské fakulty Univerzity Palackého a Fakultní nemocnice Olomouc
- 5 1. ortopedická klinika 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha
PURPOSE OF THE STUDY:
The study aims to quantify the costs of a hospital stay of patients with periprosthetic joint infection after total hip arthroplasty throughout the period of treatment.
MATERIAL AND METHODS:
The group included patients who have been treated at our department for infection as a complication of total hip replacement since 1 January 2011, who have been provided with treatment (including complications) exclusively at the departments of Nemocnice České Budějovice, a.s. and whose treatment can be considered completed in 2019. The patients were included in the study regardless of the type of infection and method of treatment. The group consisted of 36 patients (16 men and 20 women). There were 3 cases of early postoperative infection, 14 cases of late postoperative infection and 19 cases of hematogenous infection. The group includes 8 patients treated by a one-stage reimplantation, 19 patients managed by a two-stage reimplantation, 6 patients treated by a revision surgery with implant retention, and 3 patients in whom only the implant removal was possible.
In selected patients, all the reported points for all the hospital stays and costs incurred on a separately charged material were ascertained and the final sum was compared with the reimbursement obtained by the hospital in the DRG system valid for the respective year of treatment. The total costs were analysed and also an analysis by type of infection and method of treatment was carried out.
RESULTS:
The average costs of managing infection as a complication of total hip arthroplasty at our department amounted to CZK 320 065 (CZK 56 995 - CZK 953 614), the reimbursement in respect of the monitored cases in the DRG system equalled CZK 220 503 (CZK 89 149 - CZK 589 974). The aforementioned suggests that the average loss per treated patient is CZK 99 562 (CZK + 63 372 - CZK -428 499).
DISCUSION
Care associated with infections as a complication of total hip arthroplasty is very costly and these costs are not fully covered by the reimbursement from the health insurance companies. In the Czech Republic, these costs have not been quantified as yet, therefore it is only possible to compare the costs with international publications arriving at similar conclusions and with own monitoring of the costs of periprosthetic joint infections after total hip arthroplasty. The most economically efficient is the one-stage replacement which, however, is not suitable for all the patients, and the two-stage reimplantation continues to be the gold standard. In our study, the most expensive was found to be the treatment of periprosthetic joint infection after total hip arthroplasty, in which also the highest financial loss is reported.
CONCLUSIONS:
Due to the very high costs of treatment for periprosthetic joint infections after total hip arthroplasty, it is necessary to exert maximum efforts to prevent periprosthetic joint infections and to consider a change in the method of financing, particularly in centres to which patients are referred from other centres in order to make this treatment economically viable.
Keywords: total hip arthroplasty, PJI - periprosthetic joint infection, economic analysis
Published: August 1, 2019 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection. J Bone Joint Surg Am. 2006;88:869-882.
Go to original source...
Go to PubMed...
- Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of revision total knee arthroplasty in the United States. Clin. Orthop Relat Res. 2010;468:45-51.
Go to original source...
Go to PubMed...
- Deirmengian C, Hallab N, Tarabishy A, Della Valle C, Jacobs JJ, Lonner J, Booth RE. Jr Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res. 2010;468:2017-2023.
Go to original source...
Go to PubMed...
- Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Combined measurement of synovial fluid α-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection. J. Bone Joint Surg Am. 2014;3:96:1439-1445.
Go to original source...
Go to PubMed...
- Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res. 2014;472:3254-3262.
Go to original source...
Go to PubMed...
- Gallo J. Předoperační diagnostika infekcí kloubních náhrad. Ortopedie. 2017;11:75-81.
- Garrido-Gómez J, Arrabal-Polo MA, Girón-Prieto MS, Cabello-Salas J, Torres-Barroso J, Parra-Ruiz J. Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia. J Arthroplasty. 2013;28:1057-1060.
Go to original source...
Go to PubMed...
- Haenle M, Skripitz C, Mittelmeier W, Skripitz R. Economic Impact of Infected Total Knee Arthroplasty. The Scientific World Journal. 2012; 196515.
Go to original source...
Go to PubMed...
- Haenle M, Skripitz C, Mittelmeier W, Skripitz R. Economic Impact of Infected Total Hip Arthroplasty in the German diagnosis-related groups system. Orthopade. 2012;41:467-476.
Go to original source...
Go to PubMed...
- Jahoda D, Nyč O, Pokorný D, Landor I, Sosna A. Antibiotika v prevenci infekčních komplikací u operací kloubních náhrad. Acta Chir Orthop Traumatol Cech. 2006;73:108-114.
Go to original source...
Go to PubMed...
- Jahoda D, Nyč O, Šimsa J, Kučera E, Hanek P, Chrz P, Pokorný D, Tawa N, Landor I, Sosna A. Výskyt pozdní hematogenní infekce kloubních náhrad v našem souboru a návrh systému prevence. Acta Chir Orthop Traumatol Cech. 2007;74:397-400.
Go to original source...
Go to PubMed...
- Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection, Lancet. 2016;387:386-394.
Go to original source...
Go to PubMed...
- Kapadia BH, McElroy MJ, Issa K, Johnson AJ, Bozic KJ, Mont MA. The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center. J Arthroplasty. 2014;29:929-932.
Go to original source...
Go to PubMed...
- Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009;467:2606-2612.
Go to original source...
Go to PubMed...
- Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984-991.
Go to original source...
Go to PubMed...
- Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States J Arthroplasty. 2012;27:61-65.e1.
Go to original source...
Go to PubMed...
- Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res. 2010;468:52-56.
Go to original source...
Go to PubMed...
- Kurtz SM, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780-785.
Go to original source...
Go to PubMed...
- Kurtz S, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, Kärrholm J, Garellick G, Havelin LI, Furnes O, Malchau H, Lau E. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89(Suppl 3):144.
Go to original source...
Go to PubMed...
- Landor I, Vavřík P, Jahoda D. Obecné principy léčby infekce kloubních náhrad. Acta Chir Orthop Traumatol Cech. 2005;72:183-191.
Go to PubMed...
- Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006;42:4471-78.
Go to original source...
Go to PubMed...
- Musil D, Stehlík J, Abrman K. Algoritmus diagnostiky a léčby u infekce totálních náhrad. Ortopedie. 2017;11:89-96.
- Ochsner PE, Borens O, Bodler P, Broger I, Eich G, Hefti F, Maurer T, Nötzli H, Seiler S, Suva D, Trampuz A, U kay I, Vogt M, Zimmerli W. Infections of the musculosceletal system. Basic principles, prevention, diagnosis and treatment. Grandvaux, Switzerland, 2014.
- Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the infectious diseases society of America. Clinical Infectious Diseases, 2013;56:1-25.
Go to original source...
Go to PubMed...
- Parisi TJ, Konopka JF, Bedair HS. What is the long-term economic societal effect of periprosthetic infections after THA? A Markov analysis. Clin Orthop Relat Res. 2017;475:1891-1900.
Go to original source...
Go to PubMed...
- Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty. 2010;25(6 Suppl):103-107.
Go to original source...
Go to PubMed...
- Parvizi J, Zmistowski B, Adeli B. Periprosthetic joint infection: treatment options. Orthopedics. 2010;33:659.
Go to original source...
Go to PubMed...
- Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992-2994.
Go to original source...
Go to PubMed...
- Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect. 1993;42:349-351.
Go to PubMed...
- Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly. 2005;135:243-251.
Go to original source...
Go to PubMed...
- Vavřík P, Landor I, Jahoda D. Zkušenosti s léčbou infektu aloplastiky kolenního kloubu. Acta Chir Orthop Traumatol Cech. 2000;6:121-127.
- Zimmerli W, Trampuz A, Ochsner P.E. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-1654.
Go to original source...
Go to PubMed...